Navigation Links
CU awarded $48.4 million from NIH to advance translational research from bench to bedside
Date:10/22/2013

AURORA, Colo. (Oct. 22, 2013) Research has found that what is most important to an aging senior citizen is independence. A collaborative study through the Colorado Clinical and Translational Sciences Institute (CCTSI) and the Center for African American Health is working with African American women to discuss the importance of walking. Yes, the simple act of walking allows seniors to keep their independence, keep their balance, keep them in their homes and keep them healthy.

This is one of many programs that the CCTSI is helping to fund. And that funding just got a big addition.

CCTSI has received a $48.4 million, five-year grant from the National Institutes of Health to continue to accelerate the translation of research discoveries into improved patient care and public health. CU is just one of 15 institutions in the U.S. selected this month to receive an NIH Clinical and Translational Science Award, or CTSA.

"This award allows us to continue seamless and safe translation of biomedical research. The clinical discoveries that are made will help improve human health," said Richard Traystman, PhD, vice chancellor of research.

"The CCTSI has made great strides and we fully support the work facilitated by both clinical and research scientists which ultimately impact the lives of our community," said Richard D. Krugman, MD, vice chancellor for health affairs and dean of the School of Medicine.

The CCTSI is a collaborative enterprise between the University of Colorado Denver|Anschutz Medical Campus, CU Boulder, Colorado State University and six major hospitals. These hospitals are: University of Colorado Hospital, Children's Hospital Colorado, Denver Health, National Jewish Health, Denver Veterans Affairs Medical Center and Kaiser Permanente of Colorado. CCTSI also includes health care organizations and local communities, both rural and inner city.

"We appreciate the NIH's continued support and commitment to our Institute. This award allows us to be a continuous voice in the broader discussion of improving health while reducing costs," said Ronald J. Sokol, MD, principal investigator and CCTSI director.

Some of the goals of the CCTSI are to:

  • Expand the statewide academic home for clinical and translational research.
  • Implement new clinical research management strategies to improve quality, safety, efficiency, cost-effectiveness and innovative team science as well as introduce new software systems and workflows.
  • Centralize the delivery of resources, services and technologies.
  • Incorporate key concepts of community engagement into the full spectrum of translational research.
  • Increase the translational research workforce capacity through a broad curriculum of education, training and career development opportunities.

A rigorous tracking, assessment and evaluation program with a formal quality and process improvement component will ensure the best use of resources while protecting the safety of research study participants. These programs are centralized at the CU Anschutz Medical Campus.

The NIH started the CTSA program in 2006 as a research vehicle in the health care reform movement to provide higher quality and more affordable health care. CU received its first round of CTSA funding in 2008.

Since 2008, the CCTSI has

  • Established new infrastructure and improved resources and services for investigators
  • Tripled the number of training and education programs supporting the lifespan of an investigational career;
  • Administratively centralized and expanded the breadth of clinical research capacity and expertise;
  • Established system-wide informatics capabilities
  • Promoted team science and encouraged interdisciplinary research through pilot grant programs and technology cores;
  • Established an extensive community engagement program, from small towns to the inner city, from professors to farmers.
  • Streamlined processes and reduced the regulatory burden for investigators
  • Created an academic home for clinical and translational scientists and trainees.

Eventually, though innovative research and dissemination, CCTSI should help improve the health care of all of Colorado's more than 4 million residents and the 1,300 physician practices and 300 hospitals that serve them.


'/>"/>

Contact: Jackie Brinkman
jackie.brinkman@ucdenver.edu
303-724-1525
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. How does aging affect cancer? Einstein awarded $2.8m grant to answer NCI provocative question
2. LDM Global eDiscovery Professional, Jennifer Holt, is Awarded CEDS Certification
3. Painter Dallas TX and House Painting Dallas "Best of the Best" Awarded to Five Star Painting in Dallas for Excellence by Follow Media Consulting, Inc.
4. Asthma attack prevention proposal awarded NIH New Innovator grant
5. Appliance Repair Annapolis "Best of the Best" Awarded to Mr. Appliance of Central Maryland for Excellence by Follow Media Consulting, Inc.
6. Nearly $4 million awarded to GW School of Public Health and Health Services researchers
7. Financial Advisor Plano, TX and Financial Planner Plano, TX "Best of the Best" Awarded to VAL-Trust Capital Partners, LLC for Excellence by Follow Media Consulting, Inc.
8. U.S. Preventive Medicine Awarded Exclusive, Workplace Health Program for Innovative Self-Funded Health Benefits Plan, Health Options Plus™
9. Appliance Repair Bowie MD "Best of the Best" Awarded to Mr. Appliance of Central Maryland for Excellence by Follow Media Consulting, Inc.
10. Home Care Assistance Awarded 2013 Home Care Pulse Endorsed National Provider and 2013 Best of Home Care® Endorsed National Provider
11. Scalability Experts Is Awarded “Outstanding Partner for 2013” by HP and Microsoft at Worldwide Partner Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 bottles ... AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing ... an over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... growing as it continues developing an ANSI-approved, consensus-based American National Standard for ... plans to publish the first ANSI-approved GMP standard for dietary supplements this ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... , March 29, 2017  Spiral Therapeutics, ... agreement with Bionure Farma, S.L. for the worldwide ... to BN119 in the field of otolaryngology for ... sales-based royalties. The agreement provides Spiral with ... with a differentiated product profile. Under the terms ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: